Results 181 to 190 of about 25,315 (305)
Abstract Purpose Proliferative diabetic retinopathy (PDR) is one of the leading causes of blindness in working‐age adults. We have previously shown that the risk of PDR is significantly elevated in individuals with intrauterine exposure to famine. However, the genetic mechanisms mediating this association remain unknown.
Olena Fedotkina +7 more
wiley +1 more source
The association between two common levels of apolipoprotein and chronic obstructive pulmonary disease: A Mendelian randomized study. [PDF]
Chen C +8 more
europepmc +1 more source
Structure-Function Studies of Recombinant Apolipoproteins
Bioreactor-based foam fractionation is a method developed for the expression and purification of apolipoprotein alpha helix bundle domains for their use as nanoparticle scaffold protein components.
Lethcoe, Kyle
core
Neuritic plaques increase in the intermediate stage of Alzheimer's neuropathological change. The intermediate stage of Alzheimer's disease was investigated by transcriptomics and immunohistochemistry. This revealed that inflammasome sensors NLRP1, NLRP3, and AIM2 oligomerize with ASC speck to form the inflammasome complex and initiate the downstream ...
Juan Pablo de Rivero Vaccari +10 more
wiley +1 more source
Exploring the evolving role of apolipoproteins in oncology: global trends and emerging frontiers. [PDF]
Tian D +10 more
europepmc +1 more source
We generated digital pathologic algorithms (AI‐based modules that can be freely shared) to: optimize the sampling (ROI) for diagnosis of ADNC‐related tau pathology; compare/transition between Aperio and HALO platforms; and rationalize severe Braak NFT staging, so that all Braak‐VI cases had dementia, and all Braak‐V cases had MCI or dementia.
Ryan K. Shahidehpour +10 more
wiley +1 more source
Challenging the prokaryotic MGE‐defense origin of eukaryotic RNA editing
mLife, EarlyView.
Yuange Duan +4 more
wiley +1 more source
Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
Abstract Incretin‐based therapies have gained momentum as a key strategy for reducing cardiovascular risk in individuals with obesity and/or type 2 diabetes (T2D). It remains unclear whether the cardiovascular benefits reflect a direct reduction in atherogenic lipoproteins—namely, low‐density lipoproteins (LDL), very low‐density lipoproteins (VLDL) and
Andrea Baragetti, Giuseppe Danilo Norata
wiley +1 more source
Characterizing lipoprotein profiles in coronary atherosclerosis development through quantitative lipidomics and proteomics approaches. [PDF]
Takeda H +8 more
europepmc +1 more source

